193 related articles for article (PubMed ID: 32718750)
1. Radiosynthesis and evaluation of
Willmann M; Ermert J; Prante O; Hübner H; Gmeiner P; Neumaier B
Nucl Med Biol; 2021 Jan; 92():43-52. PubMed ID: 32718750
[TBL] [Abstract][Full Text] [Related]
2. Labeling of benzodioxin piperazines with fluorine-18 as prospective radioligands for selective imaging of dopamine D4 receptors.
Kügler F; Ermert J; Coenen HH
J Labelled Comp Radiopharm; 2013 Oct; 56(12):609-18. PubMed ID: 24285237
[TBL] [Abstract][Full Text] [Related]
3. Development of two fluorine-18 labeled PET radioligands targeting PDE10A and in vivo PET evaluation in nonhuman primates.
Stepanov V; Takano A; Nakao R; Amini N; Miura S; Hasui T; Kimura H; Taniguchi T; Halldin C
Nucl Med Biol; 2018 Feb; 57():12-19. PubMed ID: 29223715
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, radiofluorination, and in vitro evaluation of pyrazolo[1,5-a]pyridine-based dopamine D4 receptor ligands: discovery of an inverse agonist radioligand for PET.
Prante O; Tietze R; Hocke C; Löber S; Hübner H; Kuwert T; Gmeiner P
J Med Chem; 2008 Mar; 51(6):1800-10. PubMed ID: 18307287
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 18F-labeled benzodioxine piperazine-based dopamine D4 receptor ligands: lipophilicity as a determinate of nonspecific binding.
Kügler F; Sihver W; Ermert J; Hübner H; Gmeiner P; Prante O; Coenen HH
J Med Chem; 2011 Dec; 54(24):8343-52. PubMed ID: 22039961
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of candidate PET radioligands for corticotropin-releasing factor type-1 receptors.
Lodge NJ; Li YW; Chin FT; Dischino DD; Zoghbi SS; Deskus JA; Mattson RJ; Imaizumi M; Pieschl R; Molski TF; Fujita M; Dulac H; Zaczek R; Bronson JJ; Macor JE; Innis RB; Pike VW
Nucl Med Biol; 2014 Jul; 41(6):524-35. PubMed ID: 24793011
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of fluorine-substituted 1H-pyrrolo[2,3-b]pyridine derivatives for dopamine D4 receptor imaging.
Oh SJ; Lee KC; Lee SY; Ryu EK; Saji H; Choe YS; Chi DY; Kim SE; Lee J; Kim BT
Bioorg Med Chem; 2004 Nov; 12(21):5505-13. PubMed ID: 15465327
[TBL] [Abstract][Full Text] [Related]
8. Brain penetrant small molecule (18)F-GnRH receptor (GnRH-R) antagonists: Synthesis and preliminary positron emission tomography imaging in rats.
Olberg DE; Bauer N; Andressen KW; Hjørnevik T; Cumming P; Levy FO; Klaveness J; Haraldsen I; Sutcliffe JL
Nucl Med Biol; 2016 Aug; 43(8):478-89. PubMed ID: 27236283
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, lipophilic properties, and binding affinities of potential ligands in positron emission tomography (PET) for visualization of brain dopamine D4 receptors.
Lacivita E; De Giorgio P; Colabufo NA; Berardi F; Perrone R; Niso M; Leopoldo M
Chem Biodivers; 2014 Feb; 11(2):299-310. PubMed ID: 24591318
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of N-{2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl}-3-[(11) C]methoxybenz-amide, a positron emission tomography (PET) radioligand for dopamine D4 receptors, in rodents.
Leopoldo M; Selivanova SV; Müller A; Lacivita E; Schetz JA; Ametamey SM
Chem Biodivers; 2014 Sep; 11(9):1298-308. PubMed ID: 25238073
[TBL] [Abstract][Full Text] [Related]
11. Click chemistry based synthesis of dopamine D4 selective receptor ligands for the selection of potential PET tracers.
Banerjee A; Maschauer S; Hübner H; Gmeiner P; Prante O
Bioorg Med Chem Lett; 2013 Nov; 23(22):6079-82. PubMed ID: 24100078
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation in rats of the dopamine D2/3 receptor agonist 18F-AMC20 as a potential radioligand for PET.
Shalgunov V; van Wieringen JP; Janssen HM; Fransen PM; Dierckx RA; Michel MC; Booij J; Elsinga PH
J Nucl Med; 2015 Jan; 56(1):133-9. PubMed ID: 25476538
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, radiolabeling, and in vivo evaluation of carbon-11 labeled N-[2-[4-(3-cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide, a potential positron emission tomography tracer for the dopamine D(4) receptors.
Lacivita E; De Giorgio P; Lee IT; Rodeheaver SI; Weiss BA; Fracasso C; Caccia S; Berardi F; Perrone R; Zhang MR; Maeda J; Higuchi M; Suhara T; Schetz JA; Leopoldo M
J Med Chem; 2010 Oct; 53(20):7344-55. PubMed ID: 20873719
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a novel series of fluorine-18-labeled imidazobenzodiazepines as potential new positron emission tomography radioligands for the GABAA receptor.
Jackson A; Battle MR; O'Shea DM; Chau WF; Gaeta A; Brown SL; Ewan AL; Jones CL; Jones PA; Woodcraft JL; Bouvet DR; Guilbert BB; Trigg W
Nucl Med Biol; 2014 Feb; 41(2):196-202. PubMed ID: 24480268
[TBL] [Abstract][Full Text] [Related]
15. Syntheses and pharmacological evaluation of two potent antagonists for dopamine D4 receptors: [11C]YM-50001 and N-[2-[4-(4-Chlorophenyl)-piperizin-1-yl]ethyl]-3-[11C]methoxybenzamide.
Zhang MR; Haradahira T; Maeda J; Okauchi T; Kawabe K; Noguchi J; Kida T; Suzuki K; Suhara T
Nucl Med Biol; 2002 Feb; 29(2):233-41. PubMed ID: 11823129
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and preliminary evaluation of [18F]-labeled 2-oxoquinoline derivatives for PET imaging of cannabinoid CB2 receptor.
Turkman N; Shavrin A; Paolillo V; Yeh HH; Flores L; Soghomonian S; Rabinovich B; Volgin A; Gelovani J; Alauddin M
Nucl Med Biol; 2012 May; 39(4):593-600. PubMed ID: 22226022
[TBL] [Abstract][Full Text] [Related]
17. In Vitro and In Vivo Characterization of Selected Fluorine-18 Labeled Radioligands for PET Imaging of the Dopamine D3 Receptor.
Nebel N; Maschauer S; Kuwert T; Hocke C; Prante O
Molecules; 2016 Aug; 21(9):. PubMed ID: 27589704
[TBL] [Abstract][Full Text] [Related]
18. Radiosynthesis and evaluation of new α1-adrenoceptor antagonists as PET radioligands for brain imaging.
Airaksinen AJ; Finnema SJ; Balle T; Varnäs K; Bang-Andersen B; Gulyás B; Farde L; Halldin C
Nucl Med Biol; 2013 Aug; 40(6):747-54. PubMed ID: 23810488
[TBL] [Abstract][Full Text] [Related]
19. Syntheses and in vitro evaluation of fluorinated naphthoxazines as dopamine D2/D3 receptor agonists: radiosynthesis, ex vivo biodistribution and autoradiography of [(18)F]F-PHNO.
Vasdev N; Seeman P; Garcia A; Stableford WT; Nobrega JN; Houle S; Wilson AA
Nucl Med Biol; 2007 Feb; 34(2):195-203. PubMed ID: 17307127
[TBL] [Abstract][Full Text] [Related]
20. 18F-Labeled FAUC 346 and BP 897 derivatives as subtype-selective potential PET radioligands for the dopamine D3 receptor.
Hocke C; Prante O; Salama I; Hübner H; Löber S; Kuwert T; Gmeiner P
ChemMedChem; 2008 May; 3(5):788-93. PubMed ID: 18306190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
